200 related articles for article (PubMed ID: 2497223)
1. Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2.
Edwards CA; Dieguez C; Scanlon MF
J Endocrinol; 1989 Apr; 121(1):31-6. PubMed ID: 2497223
[TBL] [Abstract][Full Text] [Related]
2. Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog.
Muruais J; Peñalva A; Dieguez C; Casanueva FF
J Endocrinol; 1993 Aug; 138(2):211-8. PubMed ID: 8228729
[TBL] [Abstract][Full Text] [Related]
3. Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat.
Mallo F; Alvarez CV; Benitez L; Burguera B; Coya R; Casanueva FF; Dieguez C
Neuroendocrinology; 1993; 57(2):247-56. PubMed ID: 8510800
[TBL] [Abstract][Full Text] [Related]
4. Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 stimulate growth hormone release through distinct receptor sites.
Blake AD; Smith RG
J Endocrinol; 1991 Apr; 129(1):11-9. PubMed ID: 1674284
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH)-releasing peptide and GH releasing hormone stimulate GH release from subpopulations of somatotrophs in rats.
Mitani M; Kaji H; Abe H; Chihara K
J Neuroendocrinol; 1996 Nov; 8(11):825-30. PubMed ID: 8933359
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism.
Pimentel-Filho FR; Ramos-Dias JC; Ninno FB; Façanha CF; Liberman B; Lengyel AM
Clin Endocrinol (Oxf); 1997 Mar; 46(3):295-300. PubMed ID: 9156038
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
[TBL] [Abstract][Full Text] [Related]
8. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
Arvat E; di Vito L; Maccagno B; Broglio F; Boghen MF; Deghenghi R; Camanni F; Ghigo E
Peptides; 1997; 18(6):885-91. PubMed ID: 9285939
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
[TBL] [Abstract][Full Text] [Related]
10. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells.
Dieguez C; Foord SM; Peters JR; Hall R; Scanlon MF
Endocrinology; 1985 Mar; 116(3):1066-70. PubMed ID: 3918846
[TBL] [Abstract][Full Text] [Related]
11. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.
Bercu BB; Yang SW; Masuda R; Walker RF
Endocrinology; 1992 May; 130(5):2579-86. PubMed ID: 1315249
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
Malozowski S; Hao EH; Ren SG; Marin G; Liu L; Southers JL; Merriam GR
J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome.
Micić D; Kendereski A; Popović V; Sumarac M; Zorić S; Macut D; Dieguez C; Casanueva F
Clin Endocrinol (Oxf); 1996 Oct; 45(4):385-90. PubMed ID: 8959075
[TBL] [Abstract][Full Text] [Related]
14. Ipamorelin, the first selective growth hormone secretagogue.
Raun K; Hansen BS; Johansen NL; Thøgersen H; Madsen K; Ankersen M; Andersen PH
Eur J Endocrinol; 1998 Nov; 139(5):552-61. PubMed ID: 9849822
[TBL] [Abstract][Full Text] [Related]
15. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
Cordido F; Peñalva A; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2) in rat anterior pituitary cells.
Akman MS; Girard M; O'Brien LF; Ho AK; Chik CL
Endocrinology; 1993 Mar; 132(3):1286-91. PubMed ID: 8095015
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone responses to growth hormone-releasing factor (1-29) in euthyroid, hypothyroid and hyperthyroid rats.
Dieguez C; Jordan V; Harris P; Foord S; Rodriguez-Arnao MD; Gomez-Pan A; Hall R; Scanlon MF
J Endocrinol; 1986 Apr; 109(1):53-6. PubMed ID: 2871123
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
[TBL] [Abstract][Full Text] [Related]
19. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging.
Ghigo E; Arvat E; Rizzi G; Goffi S; Grottoli S; Mucci M; Boghen MF; Camanni F
Eur J Endocrinol; 1994 Nov; 131(5):499-503. PubMed ID: 7952160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
